Back to top

Achillion Pharmaceuticals (ACHN) Jumps Stock Up 20.9%
June 17, 2014

Read MoreHide Full Article
Achillion Pharmaceuticals, Inc. (ACHN) was a big mover last session, as its shares rose almost 21% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend trend for the company, as the stock is now up nearly 193% in the past one-month timeframe.

In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.

Achillion Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gilead Sciences Inc. (GILD - Free Report) , ANI Pharmaceuticals, Inc. (ANIP - Free Report) and Illumina Inc. (ILMN - Free Report) . All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ANI Pharmaceuticals, Inc. (ANIP) - free report >>

Gilead Sciences, Inc. (GILD) - free report >>

Illumina, Inc. (ILMN) - free report >>

More from Zacks Tale of the Tape

You May Like